AU3735100A - Combination use of gemcitabine and tumor suppressor gene therapy in the treatment of neoplasms - Google Patents

Combination use of gemcitabine and tumor suppressor gene therapy in the treatment of neoplasms

Info

Publication number
AU3735100A
AU3735100A AU37351/00A AU3735100A AU3735100A AU 3735100 A AU3735100 A AU 3735100A AU 37351/00 A AU37351/00 A AU 37351/00A AU 3735100 A AU3735100 A AU 3735100A AU 3735100 A AU3735100 A AU 3735100A
Authority
AU
Australia
Prior art keywords
neoplasms
gemcitabine
treatment
gene therapy
tumor suppressor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37351/00A
Inventor
Jo Ann Horowitz
Loretta Lynn Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU3735100A publication Critical patent/AU3735100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU37351/00A 1999-03-19 2000-03-10 Combination use of gemcitabine and tumor suppressor gene therapy in the treatment of neoplasms Abandoned AU3735100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27301399A 1999-03-19 1999-03-19
US09273013 1999-03-19
PCT/US2000/006202 WO2000056351A2 (en) 1999-03-19 2000-03-10 Combination use of gemcitabine and tumor suppressor gene therapy in the treatment of neoplasms

Publications (1)

Publication Number Publication Date
AU3735100A true AU3735100A (en) 2000-10-09

Family

ID=23042179

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37351/00A Abandoned AU3735100A (en) 1999-03-19 2000-03-10 Combination use of gemcitabine and tumor suppressor gene therapy in the treatment of neoplasms

Country Status (2)

Country Link
AU (1) AU3735100A (en)
WO (1) WO2000056351A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2282683A1 (en) * 1997-02-18 1998-08-20 Canji, Inc. Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms

Also Published As

Publication number Publication date
WO2000056351A2 (en) 2000-09-28
WO2000056351A3 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
GB9903841D0 (en) Diagnosis and treatment of cancer
AU4838600A (en) Enhanced survival of cancer patients treated with erythropoietin and antitumor agents
HUP0201757A2 (en) Compositoins and methods for the therapy and diagnosis of lung cancer
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
HUS1500001I1 (en) Use of et743 in combination therapy with dexamethasone for treating cancer
AU2212299A (en) Compositions and methods for the treatment of tumor
HUP0004326A3 (en) Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
IL148579A0 (en) Oncolytic combinations for the treatment of cancer
AU6435398A (en) Prevention and treatment of hepatocellular cancer
AU3704800A (en) Co-administration of lucanthone and radiation for treatment of cancer
GB9811598D0 (en) Diagnosis and treatment of cancer
IL141426A0 (en) Compositions and methods for the treatment of tumor
AU6814601A (en) Use of mutant herpes viruses and anticancer agents in the treatment of cancer
IL143212A0 (en) Compositions and methods for the treatment of tumor
EP1023076A4 (en) Use of the p-ten suppressor gene in diagnosis and treatment of cancer
AU5946999A (en) Tumour therapy and imaging
IL149281A0 (en) Treatment of cancer
AU2002366195A1 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
AU3735100A (en) Combination use of gemcitabine and tumor suppressor gene therapy in the treatment of neoplasms
IL132531A0 (en) Detection and therapy of tumors
AU5871898A (en) Microparticles and their use in cancer treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase